Gaois

Search direction

Search mode

Filter results

Collections

2 results in 2 documents

  1. #2043867

    athruithe ar shubstaint ghníomhach i vacsaín shéasúrach, réamh-phaindéime nó phaindéime in aghaidh an fhliú dhaonna;

    changes to the active substance of a seasonal, pre-pandemic or pandemic vaccine against human influenza;

    Commission Delegated Regulation (EU) 2021/756 of 24 March 2021 amending Regulation (EC) No 1234/2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products (Text with EEA relevance)

  2. #3221535

    Anuas ar an iarchur dá ndéantar foráil i bpointe 3.1, le haghaidh gníomhaíochtaí rialála laistigh den chreat a bhaineann le príomh-shainchomhad a chur isteach le haghaidh vacsaín in aghaidh paindéime agus an t-athrú paindéimeach a chur isteach ina dhiaidh sin, beidh feidhm ag laghdú 100 % ar an táille sna cásanna a leanas:

    In addition to the deferral provided for in point 3.1, for regulatory activities within the framework of the submission of a core dossier for a pandemic vaccine and the follow-up submission of a pandemic variation, a fee reduction of 100 % shall apply in the following cases:

    Regulation (EU) 2024/568 of the European Parliament and of the Council of 7 February 2024 on fees and charges payable to the European Medicines Agency, amending Regulations (EU) 2017/745 and (EU) 2022/123 of the European Parliament and of the Council and repealing Regulation (EU) No 658/2014 of the European Parliament and of the Council and Council Regulation (EC) No 297/95